Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

European Innovation Council · Running

LucidWave A Novel Handheld Ultrasound Medical Imaging Probe: Prototyping, Initial Validation and Business Development

Coordinator
Katholieke Universiteit Leuven, Belgium
Runs
1 July 2022 to 31 October 2025
Status
Running
EU funding
€2.4m
Total cost
€2.4m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
101057902

What the project is doing

In the project's own words, from its summary on CORDIS.

The LucidWave Project introduces a low-cost, very capable, handheld ultrasound probe for medical imaging based on an entirely new ultrasound technology. It aims to provide a light, but powerful imaging tool to a wide range medical professionals for bed-side, point-of-care, office and operating room diagnostics. Doing so it will bring the well-known capabilities of classic ultrasound imaging closer and faster to the patient, helping not only radiologists to make better decisions, but also GP?s, nurses, veterinarians.

Consequently, much time, costs and misdiagnosis will be saved for patient and physician. The project has to following objectives: (I) Starting at TRL 4, develop and deliver 2 full functional prototypes with all parts integrated into one slim device. The capabilities will largely surpass those of current handheld devices. (II) Validate the prototype?s performance in a clinical evaluation. Together with the foundations of a Quality Management System (ISO 13485), it will provide a head start for a later formal Clinical Validation according to the new Medical Device Regulation. (III) Build an entrepreneurial and complementary team by inviting entrepreneurs-in-residence. (IV) In preparation of a start-up a complete and quantified business plan will be created, building on a solid Value Proposition Canvas (incl. user-centric design) which is developed into a Business Model Canvas.

LucidWave fits well into the EIC Transition Programme since it aims to develop a mature proof-of-concept (validated against state-of art) into a prototype ready for Clinical Validation and for scaling-up of the manufacturing. The technical part is complemented with a business strategy for a new and healthy start-up. It addresses one of the key challenges and priorities of Europe, i.e. to build a healthy society.

Topics

Who is involved

OrganisationCityCountryRole
Katholieke Universiteit LeuvenLeuvenBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI